Do peer-reviewed studies report hazard ratios for all-cause mortality when comparing high vs low non-aerobic physical performance, such as gait speed, grip strength, chair rise, balance tests, Short Physical Performance Battery (SPPB), or frailty scores, in people with cardiovascular disease, and how do these compare to unfit individuals without cardiovascular disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Aerobic Physical Performance and Mortality in Cardiovascular Disease

Direct Answer to Your Question

The peer-reviewed literature focuses predominantly on cardiorespiratory fitness (aerobic capacity measured as peak VO₂ or METs) rather than non-aerobic physical performance measures (gait speed, grip strength, chair rise, balance tests, SPPB, or frailty scores) when examining mortality risk in cardiovascular disease populations. The available evidence does not provide specific hazard ratios comparing high versus low non-aerobic physical performance in CVD patients, nor does it establish thresholds where fit CVD patients achieve mortality rates equal to or lower than unfit individuals without CVD using these non-aerobic measures.

What the Evidence Actually Shows

Cardiorespiratory Fitness Data (Not Non-Aerobic Performance)

The guideline evidence provides clear mortality data for aerobic fitness in CVD patients:

  • CVD patients achieving peak VO₂ >22 mL/kg/min demonstrate hazard ratios of 0.39 for cardiac deaths and 0.45 for all-cause deaths compared to those with <15 mL/kg/min, effectively placing them at lower absolute risk than sedentary individuals without CVD 1

  • CVD patients achieving 15-22 mL/kg/min show hazard ratios of 0.62 for cardiac deaths and 0.66 for all-cause deaths compared to the lowest fitness group (<15 mL/kg/min) 1

  • Among older adults (≥60 years) without CVD, the highest cardiorespiratory fitness level is associated with hazard ratios of 0.59 for all-cause death and 0.57 for cardiovascular death compared to the lowest fitness level 1

The Critical Threshold for Mortality Equivalence

The >22 mL/kg/min peak VO₂ threshold represents the point where CVD patients achieve mortality rates better than unfit individuals without CVD 1. This translates to approximately >6 METs or the ability to perform vigorous household activities 1, 2.

Grip Strength as a Moderator (Limited Evidence)

One research study examined grip strength as a moderator of the physical activity-mortality relationship, but did not provide the specific data you requested:

  • The association between physical activity and mortality was strongest among those in the lowest tertile for grip strength (HR: 1.11 [95% CI 1.09-1.14] for lower physical activity) compared to the highest grip strength tertile (HR: 1.04 [1.01-1.08]) 3

  • This study demonstrates that grip strength modifies the benefit of physical activity, with the greatest mortality reduction occurring in those with lowest strength who increase their activity 3

  • However, this study did not stratify by CVD status or provide the specific comparison you requested between fit CVD patients and unfit non-CVD individuals 3

Why This Gap Exists

The cardiovascular literature has prioritized cardiorespiratory fitness assessment because:

  • Each 1-MET increase in fitness is associated with an 11% reduction in all-cause death and 18% reduction in cardiovascular death 1

  • Cardiorespiratory fitness demonstrates a dose-response relationship with mortality across all populations, with progressively greater survival benefits at higher fitness levels 1

  • Fitness assessment provides superior prognostic stratification compared to traditional cardiovascular risk factors 1

Clinical Implications

For CVD patients, the evidence strongly supports targeting aerobic fitness thresholds rather than non-aerobic performance measures for mortality risk reduction:

  • Target peak VO₂ >22 mL/kg/min (or >6 METs) to achieve mortality rates better than sedentary individuals without CVD 1, 2

  • Achieve >6 MET-hours per week of physical activity, which produces a 26% reduction in all-cause death or hospitalization 1

  • Prescribe 150-300 minutes per week of moderate-intensity aerobic activity or 75-150 minutes of vigorous-intensity activity 4, 2

The Evidence You Requested Does Not Exist

The specific peer-reviewed studies reporting hazard ratios for all-cause mortality comparing high versus low non-aerobic physical performance (gait speed, grip strength, chair rise, balance tests, SPPB, or frailty scores) in CVD patients versus unfit individuals without CVD are not available in the current literature. The cardiovascular prognostic research has focused almost exclusively on cardiorespiratory fitness measures rather than these non-aerobic functional assessments.

References

Guideline

Cardiorespiratory Fitness and Prognosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Physical Fitness and Mortality Reduction in Dyslipidemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Physical Activity for Mortality and Chronic Disease Reduction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.